EMILY O'BRIEN: Open Payments
NPI 1427566439 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 53 payments from 15 companies in 2025. Trend: 2023 $651 · 2024 $1,036 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $355 |
| UCB, Inc. | 4 | $77 |
| Neurocrine BioSciences, Inc. | 4 | $73 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Lundbeck LLC | 3 | $65 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| GE HEALTHCARE | 1 | $30 |
Products named: QULIPTA, UBRELVY, INGREZZA, Symbravo, VYEPTI, BOTOX, Rystiggo, CREXONT.
Industry payments across OH — which companies pay providers there.
